Search

Your search keyword '"Pôle Biologie [CHU Toulouse]"' showing total 510 results

Search Constraints

Start Over You searched for: Author "Pôle Biologie [CHU Toulouse]" Remove constraint Author: "Pôle Biologie [CHU Toulouse]"
510 results on '"Pôle Biologie [CHU Toulouse]"'

Search Results

1. Low serum neutralization of Omicron variants a month after AZD7442 prophylaxis initiation

2. A diagnostic protocol designed for determining allergic causes in patients with blood eosinophilia

3. Post-vaccination SARS-CoV-2 antibody kinetics and protection duration against Omicron in elderly population

4. Sotrovimab to prevent severe COVID-19 in high-risk patients infected with Omicron BA.2

5. Heterogeneity in long-term outcomes for patients with Revised International Staging System stage II, newly diagnosed multiple myeloma

6. Early B cells repopulation in multiple sclerosis patients treated with rituximab is not predictive of a risk of relapse or clinical progression

7. Multiomic analysis of malignant pleural mesothelioma identifies molecular axes and specialized tumor profiles driving intertumor heterogeneity

8. Antenatal ultrasound features of isolated recurrent copy number variation in 7q11.23 (Williams syndrome and 7q11.23 duplication syndrome)

9. Hepatitis E Virus-Related Cirrhosis in Kidneyand Kidney-Pancreas-Transplant Recipients

10. When Nudges backfire : Evidence from a Randomized Field Experiment to Boost Biological Pest Control

11. Higher convergence of human-great ape enteric eukaryotic viromes in central African forest than in a European zoo: A One Health analysis

12. Early detection of WT1 measurable residual disease identifies high-risk patients, independent of transplantation in AML

13. In Adults with Ph-Negative Acute Lymphoblastic Leukemia (ALL), Age-Adapted Chemotherapy Intensity and MRD-Driven Transplant Indication Significantly Reduces Treatment-Related Mortality (TRM) and Improves Overall Survival - Results from the Graall-2014 Trial

14. Evidence of co-infections during Delta and Omicron SARS-CoV-2 variants co-circulation through prospective screening and sequencing

15. Rotavirus meningitis in an adult with transient aphasia

16. Human Cytomegalovirus Modifies Placental Small Extracellular Vesicle Composition to Enhance Infection of Fetal Neural Cells In Vitro

17. The oxygen carrier M101 alleviates complement activation, which may be beneficial for donor organ preservation

18. Evaluation of 4 quantification methods for monitoring 16 antibiotics and 1 beta-lactamase inhibitor in human serum by high-performance liquid chromatography with tandem mass spectrometry detection

19. Maribavir use in practice for cytomegalovirus infection in French transplantation centers

20. Novel DNA polymerase mutations conferring cytomegalovirus resistance: input of BAC-recombinant phenotyping and 3D model

21. Immune thrombocytopenia and pregnancy: an exposed/nonexposed cohort study

22. Editorial: Epigenetic aspects of autoimmune diseases

23. Resistance mutations in SARS-CoV-2 omicron variant after tixagevimab-cilgavimab treatment

24. Can the COVID-19 Pandemic Improve the Management of Solid Organ Transplant Recipients?

25. Immune Checkpoint Blockade Plus Interferon-Γ Add-On Antifungal Therapy in the Treatment of Refractory Covid-Associated Pulmonary Aspergillosis and Cerebral Mucormycosis [Case Report]

26. Obinutuzumab and idelalisib in symptomatic patients with relapsed/refractory Waldenström macroglobulinemia

27. IL-6 deficiency attenuates murine diet-induced non-alcoholic steatohepatitis

28. Case Report: Presence of Anti-MAG in the CSF Can Be Associated With a Neurodegenerative Process With Frontal Involvement

29. Influence of immune escape and nasopharyngeal virus load on the spread of SARS-CoV-2 Omicron variant

30. Novel T cell interferon gamma release assay (IGRA) using spike recombinant protein for COVID19 vaccine response and Nucleocapsid for SARS-Cov2 response

31. COVID-19 pandemic period, where are the seasonal viruses?

32. Influence of vaccination and prior immunity on the dynamics of Omicron BA.1 and BA.2 sub-variants

33. Immunopathological manifestations in Kabuki syndrome: a registry study of 177 individuals

34. Humoral and Cellular Immune Responses of Solid Organ Transplant Patients on Belatacept to Three Doses of mRNA-Based Anti-SARS-CoV-2 Vaccine

35. Influence of treatment with neutralizing monoclonal antibodies on the SARS-CoV-2 nasopharyngeal load and quasispecies

36. Heterologous ChAdOx1-S/BNT162b2 Vaccination: Neutralizing Antibody Response to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

37. Resistance mutations in SARS-CoV-2 omicron variant in patients treated with sotrovimab

38. A Randomised Phase II Study of Azacitidine (AZA) Alone or with Lenalidomide (LEN), Valproic Acid (VPA) or Idarubicin (IDA) in Higher-Risk MDS or Low Blast AML: GFM's 'Pick a Winner' Trial, with the Impact of Somatic Mutations

39. All-oral triplet combination with ixazomib, lenalidomide, and dexamethasone in newly diagnosed transplant-eligible myeloma patients: final results of the phase 2 IFM study 2013-06

40. TP53 mutations at codon 234 are associated with chlorambucil treatment in chronic lymphocytic leukemia

41. Real-world costs of illness of Hodgkin and the main B-Cell Non-Hodgkin lymphomas in France

42. Does HEV‐3 subtype play a role in the severity of acute hepatitis E?

43. Sustained degradation of quality of life in a subgroup of lymphoma survivors: a two-year prospective survey

44. Hepatitis E Virus Infection: Neurological Manifestations and Pathophysiology

45. A recurrent RYR1 mutation associated with early-onset hypotonia and benign disease course

46. Can antidepressants unlock prescription of rimonabant in the fight against COVID-19?

47. Prediction of SARS-CoV-2 Variant Lineages Using the S1-Encoding Region Sequence Obtained by PacBio Single-Molecule Real-Time Sequencing

48. Evaluation of Three Quantitative Anti-SARS-CoV-2 Antibody Immunoassays

49. Glucocorticoid use as a cause of non-cellular immune response to SARS-Cov2 Spike in patients with immune system diseases

50. Anti-SARS-CoV-2 Monoclonal Antibodies in Solid-organ Transplant Patients

Catalog

Books, media, physical & digital resources